Current trends in the allocation of National Institute of Health funding of brain tumor research
The current landscape of NIH funding for brain tumor research indicates that awarded mechanisms prioritize malignant intra-axial malignancies. Despite their prevalence, skull base neoplasia is far less represented in NIH-funded studies.
Authors
- Scott Lindhorst (ORCID: https://orcid.org/0000-0002-1585-4450)
- Brian F. Saway (ORCID: https://orcid.org/0000-0002-7101-0981)
- Matheus P. Pereira
- Alicia Zukas (ORCID: https://orcid.org/0000-0002-4731-0239)
- Ben A. Strickland (ORCID: https://orcid.org/0000-0002-4620-9542)
- Noah L. Nawabi (ORCID: https://orcid.org/0000-0002-2454-6636)
- Arabinda Das (ORCID: https://orcid.org/0000-0002-0086-4760)
- Neel H. Mehta (ORCID: https://orcid.org/0000-0002-5144-4635)
- Rohan Jha
Institutions
- Harvard University (US)
- Medical University of South Carolina (US)
- MUSC Hollings Cancer Center (US)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1093/noajnl/vdae203
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health